UK markets close in 4 hours 43 minutes
  • FTSE 100

    -24.38 (-0.33%)
  • FTSE 250

    -205.78 (-1.05%)
  • AIM

    +1.61 (+0.19%)

    -0.0095 (-0.82%)

    -0.0005 (-0.04%)

    -336.96 (-2.45%)
  • CMC Crypto 200

    -2.92 (-0.76%)
  • S&P 500

    -1.14 (-0.03%)
  • DOW

    +152.93 (+0.45%)

    -2.26 (-2.96%)

    +7.10 (+0.40%)
  • NIKKEI 225

    -120.20 (-0.42%)

    -275.64 (-1.57%)
  • DAX

    -121.99 (-0.84%)
  • CAC 40

    -55.56 (-0.83%)

Lyophilisation in Pharmaceutical Market Report 2023-2033


Forecasts by Drug Type (Anti-infective, Anti-neoplastic, Anticoagulant, Hormones, Antiarrhythmic, Others), by Type of Delivery (Pre-filled Diluent Syringes, Multi-step Devices), by Indication (Autoimmune Diseases, Respiratory Diseases, Gastrointestinal Disorders, Oncology, Cardiovascular Diseases, Infectious Diseases, Metabolic Disorders, Others), by Packaging (Vials, Cartridges, Pre-filled Devices) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis.

New York, Nov. 22, 2022 (GLOBE NEWSWIRE) -- announces the release of the report "Lyophilisation in Pharmaceutical Market Report 2023-2033" -

The Lyophilisation in Pharmaceutical Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Prevalence of Chronic Diseases and Growing Number of Product Approvals Driving Market Growth

Lifestyle changes such as consumption of fast food, alcohol and tobacco smoking will increase the prevalence of chronic diseases. With the increasing number of people suffering from chronic conditions, there will be more demand for advanced drugs and treatment options, hence driving lyophilization in pharmaceuticals market growth in the future.

A majority of market players in the industry has a strong pipeline of drugs ready to hit the market. This resulted in increased number of product approvals over recent years. Several clinical studies are being undertaken by various organizations to secure product approval for extended application of lyophilization in pharmaceuticals to treat cancer and other diseases. With such continuous product approvals and increasing healthcare expenditure, the industry will experience robust growth in the future.

Increasing Demand for Stable Drug Formulations with Longer Shelf Life to Boost Industry Growth

Growing focus on development of freeze dried formulations is encouraging pharmaceutical companies to produce more stable products through lyophilization. Longer shelf-life and stability are of critical importance in the area of pharmaceuticals, biotechnology, bio-medical and bio-processing. Drug products are more stable in a dry state and enhances longer shelf-life, often as long as two to five years, making much easier to transport the product. The demand for lyophilization in pharmaceuticals is expected to grow significantly and will provide lucrative growth opportunity for the companies operating in this sector.

Substantial Number of Product Recalls Likely to Hamper Market Growth

Rising number of product recalls in the recent times may impede the growth in lyophilization in pharmaceuticals market. The U.S.FDA recently issued product recall notice to three lots of drugs from Sun Pharmaceutical Industries due to presence of glass particles in these drug lots. Furthermore, a significant increase in the number of recalls by market players due to adverse effects, the presence of foreign substances, among others may hamper the market growth.

What Questions Should You Ask before Buying a Market Research Report?

• How is the lyophilization in pharmaceuticals market evolving?

• What is driving and restraining the lyophilization in pharmaceuticals market?

• How will each lyophilization in pharmaceuticals submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?

• How will the market shares for each lyophilization in pharmaceuticals submarket develop from 2023 to 2033?

• What will be the main driver for the overall market from 2023 to 2033?

• Will leading lyophilization in pharmaceuticals markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?

• Who are the leading players and what are their prospects over the forecast period?

• What are the lyophilization in pharmaceuticals projects for these leading companies?

• How will the industry evolve during the period between 2023 and 2033? What are the implications of lyophilization in pharmaceuticals projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the lyophilization in pharmaceuticals market?

• Where is the lyophilization in pharmaceuticals market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Lyophilization in Pharmaceuticals Market today, and over the next 10 years:

• Our 260-page report provides 114 tables and 183 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Lyophilization in Pharmaceuticals Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Drug Type

• Anti-infective

• Anti-neoplastic

• Anticoagulant

• Hormones

• Antiarrhythmic

• Others

Type of Delivery

• Prefilled Diluent Syringes

• Multi-step Devices


• Autoimmune Diseases

• Respiratory Diseases

• Gastrointestinal Disorders

• Oncology

• Cardiovascular Diseases

• Infectious Diseases

• Metabolic Disorders

• Others


• Vials

• Cartridges

• Prefilled Devices

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

• U.S.

• Canada


• Germany

• UK

• France

• Italy

• Spain

• Russia

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific

Latin America

• Brazil

• Mexico

• Rest of Latin America



• South Africa

• Rest of MEA

The report also includes profiles and for some of the leading companies in the Lyophilization in Pharmaceuticals Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Aurobindo Pharma

• Bristol-Myers Squibb Company

• Cipla Inc.

• Fresenius Kabi AG

• Gilead Sciences, Inc.

• Johnson and Johnson Services, Inc.

• Merck and Co., Inc.

• Novo Nordisk A/S

• F. Hoffmann-La Roche Ltd

• Sanofi

• Takeda Pharmaceutical Company Limited

• Vetter Pharma

• Zydus Group

Overall world revenue for Lyophilization in Pharmaceuticals Market, 2023 to 2033 in terms of value the market will surpass US$282 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Lyophilization in Pharmaceuticals Market, 2023 to 2033 report help you?

In summary, our 260-page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Lyophilization in Pharmaceuticals Market, 2023 to 2033 Market, with forecasts for drug type, type of delivery, indication and packaging, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Lyophilization in Pharmaceuticals Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Lyophilization in Pharmaceuticals Market, 2023 to 2033.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001